Founded in 2012 as a spin-off from Chalmers University of Technology in Sweden, Fluicell is a public biotech company providing platforms to investigate cell behavior like never before. The company is a world leader and pioneer in open-volume microfluidics for the life sciences, and holds a strong IP and patent position with five different patent families in the estate.
The company has commercialized a product portfolio to study individual cells, primarily in the field of drug development and cell biology.
When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.